These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4314430)

  • 1. The relevance of agglutinogenic types of Bordetella pertussis in the assay of pertussis vaccines.
    Cameron J
    Prog Immunobiol Stand; 1967; 3():302-8. PubMed ID: 4314430
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the serologic type in experimental immunity against B. Pertussis.
    Pusztai Z; Joó I
    Prog Immunobiol Stand; 1967; 3():309-14. PubMed ID: 4314431
    [No Abstract]   [Full Text] [Related]  

  • 3. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Areexamination of phase IV Bordetella pertussis.
    Aprile MA
    Can J Microbiol; 1972 Dec; 18(12):1793-801. PubMed ID: 4346447
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on the immunizing capicity of B. pertussin serotypes.
    Andreescu V; Caffé I; Marion M; Ivan I
    Arch Roum Pathol Exp Microbiol; 1977; 36(2):107-14. PubMed ID: 209764
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship of the sensitizing and protective properties of pertussis antigens].
    Lebedev VS; Selezneva VP; Moshiashvili IIa; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):83-7. PubMed ID: 6285648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of culture methods on the biological activities of Bordetella pertussis].
    Hirayanagi F
    Nihon Saikingaku Zasshi; 1969 Jan; 24(1):8-14. PubMed ID: 4306072
    [No Abstract]   [Full Text] [Related]  

  • 8. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 10. The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Immunol; 1965 Oct; 95(4):643-50. PubMed ID: 4284676
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serotyping of recently isolated strains of Bordetella pertussis. II. Disparity of agglutination titers of patients' sera between antigens prepared from the Maeno and recently isolated strains (author's transl)].
    Sekiya K; Yamada M; Takamiya A; Nakase Y
    Nihon Saikingaku Zasshi; 1979 Nov; 34(6):827-35. PubMed ID: 231129
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of Bordetella strains used in the production of anti-pertussis vaccine in stationary culture].
    Castillejos Carmona R; González Pacheco M
    Salud Publica Mex; 1981; 23(6):549-53. PubMed ID: 6278653
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological studies with the desoxycholate extract of Bordetella pertussis according to Barta].
    Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jun; 130(5):461-9. PubMed ID: 4294232
    [No Abstract]   [Full Text] [Related]  

  • 15. Modified state of susceptibility to histamine in mice treated with Bordetella pertussis during the neonatal period.
    Poszgi N; David C; Ghyka G; Marion M; Andreescu V; Caffé I; Olinescu A
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Oct; 140(4):326-34. PubMed ID: 4321232
    [No Abstract]   [Full Text] [Related]  

  • 16. The reactivity of mice after hyperimmunization with Bordetella pertussis.
    David C; Pozsgi N; Andreescu V; Caffé I
    Arch Roum Pathol Exp Microbiol; 1974; 33(3-4):313-8. PubMed ID: 4377531
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y; Arai H
    Tanpakushitsu Kakusan Koso; 1972; 17(2):139-49. PubMed ID: 4337077
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of agglutinin production in mice in the determination of the definitive serotype of Bordetella pertussis.
    Bronne-Shanbury CJ
    J Hyg (Lond); 1976 Apr; 76(2):257-64. PubMed ID: 177702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotyping Bordetella pertussis strains.
    Robinson A; Ashworth LA; Irons LI
    Vaccine; 1989 Dec; 7(6):491-4. PubMed ID: 2575308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential immunogens in human pertussis: the role of fimbriae.
    Preston NW
    Dev Biol Stand; 1985; 61():137-41. PubMed ID: 2872099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.